ANI Pharmaceuticals, Inc. (ANIP)
82.72
-0.05
(-0.06%)
USD |
NASDAQ |
May 22, 16:00
82.76
+0.04
(+0.05%)
After-Hours: 20:00
ANI Pharmaceuticals EPS Diluted (Quarterly) : 1.276 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Liquidia Corp. | 0.5228 |
| Indivior Pharmaceuticals, Inc. | 0.6899 |
| Phathom Pharmaceuticals, Inc. | -0.3701 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.43M |
| Revenue (Quarterly) | 237.46M |
| Total Expenses (Quarterly) | 210.03M |
| Enterprise Value | 2.168B |
| Gross Profit Margin (Quarterly) | 51.78% |
| Profit Margin (Quarterly) | 11.55% |
| Earnings Yield | 4.77% |
| Operating Earnings Yield | 6.04% |
| Normalized Earnings Yield | 3.663 |